A股異動 | 華峯超纖(300180.SZ)逆勢升超6% 前三季淨利預增54%至71%
格隆匯9月17日丨受盈喜影響,華峯超纖(300180.SZ)盤初一度衝高至12%,現漲幅回落至6.22%,報7.85元,暫成交3.17億元,最新總市值133.7億元。華峯超纖9月16日晚間披露業績預告,預計前三季度盈利1.60億元至1.77億元,同比增長54%到71%;其中第三季度盈利1.13億元至1.30億元,同比增長100%到130%。三季度以來下游產品進入了秋冬款的開發,需求迅速恢復,產銷量同比2019年出現大幅增長。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.